The PPV was 78.4% (>92% if galectin-3-positive follicular proliferations UMP are considered as early transformed lesions or ‘thyroid cancer precursor lesions’) (Bartolazzi et al, 2001; Papotti et al, 2005), whereas the NPV was 98.6%. The gene discussed is LGALS3; the disease is thyroid cancer.